Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

GAT-1 mediated GABA uptake in rat oligodendrocytes.

Glia | 2017

Stimulated by the results of a recent paper on the effects of tiagabine, a selective inhibitor of the main GABA transporter GAT-1, on oligodendrogenesis, we verified the possibility that GAT-1 may be expressed in oligodendrocytes using immunocytochemical methods and functional assays. Light microscopic analysis of the subcortical white matter of all animals revealed the presence of numerous GAT-1+ cells of different size (from 3 to 29 µm) and morphology. An electron microscope analysis revealed that, besides fibrous astrocytes and interstitial neurons, GAT-1 immunoreactivity was present in immature and mature oligodendrocytes. Co-localization studies between GAT-1 and markers specific for oligodendrocytes (NG2 and RIP) showed that about 12% of GAT-1 positive cells in the white matter were immature oligodendrocytes, while about 15% were mature oligodendrocytes. In vitro functional assays showed that oligodendrocytes exhibit tiagabine-sensitive Na+ -dependent GABA uptake. Although relationships between GABA and oligodendrocytes have been known for many years, this is the first demonstration that GAT-1 is expressed in oligodendrocytes. The present results on the one hand definitely closes the era of "neuronal" and "glial" GABA transporters, on the other they suggest that oligodendrocytes may contribute to pathophysiology of the several diseases in which GAT-1 have been implicated to date. GLIA 2017;65:514-522.

Pubmed ID: 28071826 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-O4, clone 81 (also referred to in the literature as mAB O4) (antibody)

RRID:AB_11213138

This monoclonal targets O4 clone 81 (also referred to in the literature as mAB O4)

View all literature mentions

Anti-Oligodendrocytes, clone NS-1 (antibody)

RRID:AB_94266

This monoclonal targets Oligodendrocytes clone NS-1

View all literature mentions

Anti-NG2 Chondroitin Sulfate Proteoglycan (antibody)

RRID:AB_91789

This polyclonal targets NG2 Chondroitin Sulfate Proteoglycan

View all literature mentions

Anti-GABA transporter 1 (antibody)

RRID:AB_2620001

This polyclonal targets GABA transporter 1

View all literature mentions